ASX Announcements 

 

Orthocell Ltd ASX Link

 

Announcements released as OCC

2017

21/09/2017 Orthocell Receives New Patent for Celgro Platform Technology - PDF

14/09/2017 Appendix 4G - PDF

14/09/2017 Annual Report to shareholders - PDF

06/09/2017 Celgro Positive Safety and Performance in Human Hip Study - PDF

05/09/2017 1st Patient Recruited in Ortho-ATI Shoulder Tendon Study - PDF

31/08/2017 Preliminary Final Report - PDF

08/08/2017 Change of Director's Interest Notice SW - PDF

08/08/2017 Change of Director's Interest Notice PA - PDF

08/08/2017 Change of Director's Interest Notice MC - PDF

31/07/2017 Appendix 4C - quarterly - PDF

25/07/2017 Change of Director's Interest Notice PA - PDF

24/07/2017 Change of Director's Interest Notice MC - PDF

24/07/2017 Change of Director's Interest Notice SW - PDF

20/06/2017 Appendix 3B - PDF

30/05/2017 Ortho-ACI on Australian Register of Therapeutic Goods - PDF

01/05/2017 Ethics Approval Received for Pilot Ortho-ATI Tendon Study - PDF

28/04/2017 Appendix 4C - quarterly - PDF

11/04/2017 Response to ASX Query - PDF

10/04/2017 Response to ASX Price and Volume Query - PDF

28/03/2017 Singapore Patent for CelGro SMART Graft Received - PDF

22/03/2017 Appendix 3B - PDF

28/02/2017 Half Yearly Report and Accounts - PDF

27/02/2017 Orthocell Announces Gluteal Tendon Publication - PDF

27/02/2017 Investor Presentation - PDF

22/02/2017 Initial Results Positive for CelGro Human Nerve Regeneration - PDF

08/02/2017 Orthocell Submits US Regulatory Application for CelGro - PDF

31/01/2017 Appendix 4C - quarterly - PDF

12/01/2017 Orthocell Announces Collaboration with Johnson & Johnson - PDF

09/01/2017 OCC Receives $1.9m Tax Incentive Refund - PDF

2016

16/12/2016 Ceasing to be a Substantial Holder - PDF

15/12/2016 Ceasing to be a Substantial Holder - PDF

13/12/2016 Placement Completed - PDF

12/12/2016 Appendix 3B - PDF

07/12/2016 Change of Share Registry address - PDF

07/12/2016 Orthocell Announces $4 Million Capital Raising - PDF

02/12/2016 Investor Presentation - PDF

31/10/2016 Orthocell Receives Innovation Excellence Award - PDF 

31/10/2016 Orthocell Growth Factor Publication - PDF

26/10/2016 Notice of Annual General Meeting 2016 and Proxy Form - PDF

18/10/2016 Approval for CelGro Human Nerve Regeneration Study Received - PDF

14/10/2016 Appendix 3B - PDF

19/09/2016 Investor Presentation CelGro - PDF

14/09/2016 Research Report - PDF

12/09/2016 Full Year Statutory Accounts - PDF

12/09/2016 Amended Change of Director's Interest Notice MC - PDF

31/08/2016 Preliminary Final Report - PDF

02/08/2016 Release of Securities from Escrow - PDF

29/07/2016 Appendix 4C - quarterly - PDF

12/07/2016 Ethics Approval for Pivotal Ortho ATI Tendon Study Received - PDF

01/07/2016 Change of Director's Interest Notice SW - PDF

21/06/2016 United States Tendon Stem Cell and Scaffold Patent Obtained - PDF

17/06/2016 Chinese Patent Received Covering Celgro SMART Graft - PDF

16/06/2016 Early Positive Results for CelGro in Human Tendon Study - PDF

04/05/2016 Orthocell Receives Approval for Human Hip Study Using Celgro - PDF

02/05/2016 Orthocell receives R&D tax incentive refund - PDF

29/04/2016 Appendix 4C - quarterly - PDF

20/04/2016 Cell Factory Concept Further Validated in Leading Journal - PDF

16/03/2016 28th Annual ROTH Conference Investor Presentation - PDF

04/02/2016 Change of Director's Interest Notice SW - PDF

04/02/2016 Change of Director's Interest Notice PA - PDF

04/02/2016 Change of Director's Interest Notice LL - PDF

04/02/2016 Change of Director's Interest Notice QZ - PDF

04/02/2016 Professor Rocky Tuan Appointed to Orthocell Advisory Board - PDF

29/01/2016 Appendix 4C - quarterly - PDF

27/01/2016 Results of General Meeting - PDF

21/01/2016 Tendon Data Presented at International Hip Conference - PDF

05/01/2016 Orthocell's Cell Factory Granted Patent in U.S - PDF

 

2015

29/12/2015 Notice of General Meeting/Proxy Form - PDF

16/12/2015 Approval for Human Tendon Study Using Celgro Received - PDF

09/12/2015 Orthocell Key Scaffold Patent Granted in Canada - PDF

30/11/2015 Investor PresentationPDF

27/11/2015 Results of MeetingPDF

25/11/2015 Change in substantial holding SRVPDF

25/11/2015 Change in substantial holding MCPDF

25/11/2015 Orthocell Key Patents Granted for Celgro and Ortho-ATIPDF

23/11/2015 Becoming a substantial holder -PDF

19/11/2015 Institutional Component of US Led Placement CompletedPDF

19/11/2015 Appendix 3BPDF

18/11/2015 First Singapore Patient Receives Cartilage Therapy Ortho-ACIPDF

17/11/2015 Orthocell to raise up to $4.4 million in US Led PlacementPDF

16/11/2015 Trading HaltPDF

10/11/2015 Positive Initial Results Using Celgro in Dental StudyPDF

30/10/2015 Appendix 4C - quarterlyPDF

28/10/2015 Ortho-ATI Tendon Treatment Positive in Workers Comp StudyPDF

27/10/2015 Appendix 4G PDF

27/10/2015 Annual Report to shareholdersPDF

27/10/2015 Notice of Annual General Meeting/Proxy FormPDF 

22/10/2015 Tendon Regeneration Data Presented at South Africa MeetingPDF

15/10/2015 Technology and Data Presentations at key Ortho ConferencesPDF

08/10/2015 Orthocell Presents at Stem Cell Meeting on the MesaPDF

23/09/2015 Investor PresentationPDF

18/09/2015 Full Year Statutory Accounts - PDF

15/09/2015 Orthocell's Cell Factory validated for bone regeneration - PDF

28/08/2015 Preliminary Final Report -  PDF 

11/08/2015 Orthocell Holds Inaugural User Group Meeting -  PDF

31/07/2015 Appendix 4C - quarterlyPDF

27/07/2015 Response to ASX Aware QueryPDF

17/07/2015 Release of Securities from EscrowPDF

16/07/2015 Pipeline Cartilage Product Validated in Leading PublicationPDF

09/07/2015 Grant for World First Laboratory Grown Tendon ReceivedPDF

06/07/2015 Response to ASX Price QueryPDF

28/05/2015 Orthocell Receives R&D Tax Incentive Cash RefundPDF

25/05/2015 Orthocell presents at London Regenerative Medicine Congress - PDF

12/05/2015 Ortho-ATI Data Presented at Key International ConferencePDF

12/05/2015 Release of Shares from EscrowPDF

30/04/2015 Appendix 4C - quarterlyPDF

30/04/2015 Prestigious Journal Publishes Ortho-ATI Study FindingsPDF

17/03/2015 Investor Presentation - PDF

More OCC Announcements